Credit Suisse Ag Evolus, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Evolus, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 63,499 shares of EOLS stock, worth $634,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,499

Previous 64,509 1.57%

Holding current value

$634,990

Previous $679,000 30.78%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$9.99 - $14.91 $10,089 - $15,059	-1,010 Reduced 1.57%	63,499 $888,000
Q4 2023 Feb 08, 2024	BUY	$7.6 - $10.53 $10,579 - $14,657	1,392 Added 2.21%	64,509 $679,000
Q3 2023 Nov 13, 2023	SELL	$7.15 - $10.2 $71,271 - $101,673	-9,968 Reduced 13.64%	63,117 $576,000
Q2 2023 Aug 11, 2023	BUY	$7.23 - $10.52 $79,226 - $115,278	10,958 Added 17.64%	73,085 $531,000
Q1 2023 May 10, 2023	BUY	$7.81 - $11.05 $28,412 - $40,199	3,638 Added 6.22%	62,127 $525,000
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.95 $227,489 - $312,274	34,891 Added 147.86%	58,489 $439,000
Q3 2022 Nov 10, 2022	BUY	$7.76 - $13.72 $1,288 - $2,277	166 Added 0.71%	23,598 $191,000
Q2 2022 Aug 12, 2022	SELL	$10.22 - $13.94 $278,433 - $379,781	-27,244 Reduced 53.76%	23,432 $272,000
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $264,528 - $596,963	50,676 New	50,676 $568,000
Q2 2020 Aug 12, 2020	SELL	$3.53 - $6.17 $37,802 - $66,074	-10,709 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$3.53 - $12.21 $10,928 - $37,802	-3,096 Reduced 22.43%	10,709 $44,000
Q4 2019 Feb 12, 2020	SELL	$11.58 - $17.37 $462,910 - $694,365	-39,975 Reduced 74.33%	13,805 $168,000
Q3 2019 Nov 12, 2019	BUY	$13.91 - $19.87 $748,079 - $1.07 Million	53,780 New	53,780 $839,000
Q2 2019 Aug 14, 2019	SELL	$13.19 - $28.36 $1.46 Million - $3.15 Million	-110,933 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$12.43 - $28.91 $1.16 Million - $2.7 Million	93,338 Added 530.48%	110,933 $2.5 Million
Q4 2018 Feb 13, 2019	BUY	$10.57 - $19.29 $13,783 - $25,154	1,304 Added 8.0%	17,595 $209,000
Q3 2018 Nov 13, 2018	BUY	$17.31 - $29.82 $116,496 - $200,688	6,730 Added 70.39%	16,291 $303,000
Q2 2018 Aug 14, 2018	BUY	$6.85 - $38.49 $65,492 - $368,002	9,561 New	9,561 $268,000

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account